facebook
twitter
Login
Register
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
MD Brand Connect
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Login
Register
Select Your Interest
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
Login
Register
Home
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Home
News
FDA approves new diagnostic imaging agent to detect rare neuroendocrine tumors
DCGI grants limited approval to market Stempeucel® product for treating Critical Limb Ischemia due...
Patanjali claim on carcinogenic mustard oil not supported by quoted study
HC reserves verdict on pleas against ban on 344 FDC drugs
Reduce costs of Medical Visa, Expedite E-Visa: Hospitals to Ministry
Tell Us three months in advance of about Price Slashes: AIOCD
Patanjali comes under FSSAI scanner again, this time over its ‘crude’ oil claims
Japan to loan Rs 1584 crores to GOI to develop urban healthcare in Tamil Nadu
India: Vikram Hospital PE stake up for sale
IDMA writes to DCGI against Celluloid based capsules
Government to conduct study to assess impact of FDI in pharma industry
Fortis considering Vertical De-merger of SRL limited
Prev
Next
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our
Cookie Policy
and
Cookie Settings.
Ok